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y.Comment on ‘‘Screening for Abdominal Aortic
Aneurysm and Overall Mortality in Men’’
Dear Editor,
In his comment on the recent meta-analysis by Lindholt and
Norman1 Lederle has stressed the need to use age-adjusted
numbers of the West-Australian aneurysm screening study
in meta-analyses of population screening studies for
abdominal aortic aneurysms.2
I would like to add another comment on this study. In the
meta-analysis and the subgroup meta-analysis in response
to the comments by Lederle, the authors claim to have used
10-years follow-up data from the Viborg study. However,
the data in the meta-analysis do not correspond with the
data published in the 2006 paper of the Viborg study.3 I
have redone the analysis with the published 10 year all
cause 2006 mortality data from the Viborg study, and the
data from the Australian 65e74 years old subgroup. In
contrast to the analysis in their response to Lederle, the
effect on long-term all cause mortality fails to reach
statistical significance now, with an OR of 0.97 (95% confi-
dence interval, 0.95e1.0) (Fig. 1).
This thin line between the presence and absence of a very
small statistically significant benefit of a population
screening programme over a 10-year period indicates that
the evidence for a reduction in all cause long-termmortality
is not as robust as the authors want to show us. The potential
benefits and harms of mass screening for abdominal aortic
aneurysm with regard to long-term all cause mortality in
men older than 65 years have not yet been established, but
need further study. Future research should focus more on
the balance between the benefits of early detection and
subsequent timely operation and especially secondary
prevention, and the harm reflected by mortality and excess
morbidity caused by early intervention.
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Response to Comment on ‘‘Screening for Abdominal
Aortic Aneurysm and Overall Mortality in Men’’
Dr. Koelemay must be acknowledged for his careful review
of the meta-analysis, which has revealed a citation error in
the manuscript, for which we apologise. The data used in
the original and revised long-term meta-analyses are not
from the preliminary 10-year report from the Viborg study
as cited,1 but from the complete 7-year report,2 as for the
MASS trial.3 If the preliminary 10-year results are used in
the long-term analysis, we agree that the upper 95% C.I.
limit for the odds ratio hits 1.00.
For interpretation, one has to remember the effect of
screening and the data used in the calculation of odds
ratios. The effect is a delay of death but in the end, we are
all going to die. Thus, the most relevant statistics to use are
survival analyses. However, this would require merging of
results from all the randomised trials. This has been
attempted but without success. Consequently, we can only
use meta-analysis to address this question. However,
calculation of the pooled odds ratio is based upon the
number of deaths in the invited group versus the control
group and ultimately the numbers will be equal in the two
groups, and the OR will become 1.00. The modified calcu-
lation seems just to be a manifestation of that progression.
The existing meta-analysis still shows that screening
reduces overall mortality, and the risk association would
probably have been even stronger if seven-year results
from the Chichester and Australian Studies had been
available instead of after 15 and 12 years, respectively.References
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Sir,
We were surprised by the publication of this systematic
review. However valuable, the topic and contents are the
sameaswas publishedearlier in the British Journal of Surgery
and the Cochrane Library.1,2 Publication of a Cochrane
systematic review also in a paper-based medical journal has
been accepted to enlarge the readership to those who have
limited access to the Cochrane Library.
Theauthorsof thepresentpaper includevirtually thesame
trials and reach a similar conclusion. They even refer to the
previous systematic review, but do not (and obviously cannot)
indicate what is new in their work. Although this may be
deductable to a juxtaposition of nearly simultaneous publi-
cations, it has led to redundancy in the surgical literature.
Although we understand the interest of editors of
medical journals to include systematic reviews as poten-
tially high-referenced sources of the state-of-the-art for
their readers, they should avoid even the semblance of
double publication. For this purpose, a section with
summaries of interesting work published in other journals
would be fair to the original authors. The Journal of
Vascular Surgery has done so, but without referring to the
original authors.3 Again, such a publication appears neither
original nor ethical.
In preparing their manuscript, authors should definewhat
is known and motivate what is new in what they want toDOI of original article: 10.1016/j.ejvs.2008.06.010.
